Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Journal of Immunological Methods
|
August 1, 2000
Flow cytometric discrimination between viable neutrophils, apoptotic neutrophils and eosinophils by double labelling of permeabilized blood granulocytes
P M Kern, M Herrmann, B Stockmeyer, et al.
Cancer Immunology, Immunotherapy : CII
|
January 22, 1998
Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer
H H van Ojik, R Repp, G Groenewegen, et al.
Blood
|
August 15, 1991
Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor
R Repp, T Valerius, A Sendler, et al.
Leukemia & Lymphoma
|
July 1, 1997
HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies
T Valerius, D Elsässer, R Repp, et al.
Nucleic Acids Research
|
October 11, 1992
A novel murine homeobox gene isolated by a tissue specific PCR cloning strategy
M J Kern, D P Witte, M T Valerius, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
July 1, 1995
Gsh-1: a novel murine homeobox gene expressed in the central nervous system
M T Valerius, H Li, J L Stock, et al.
Blood
|
November 9, 2000
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma
J Honeychurch, A L Tutt, T Valerius, et al.
Nucleic Acids Research
|
December 15, 1996
An enhancer LEF-1/TCF-1 site is essential for insertion site-independent transgene expression in thymus
T L Haynes, M B Thomas, M R Dusing, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 11, 2018
Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells"
Patrick J Engelberts, Esther C W Breij, T Valerius, et al.
Anticancer Research
|
June 12, 1999
Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma
D Elsässer, H Stadick, S Stark, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Journal of Immunological Methods
|
August 1, 2000
Flow cytometric discrimination between viable neutrophils, apoptotic neutrophils and eosinophils by double labelling of permeabilized blood granulocytes
P M Kern, M Herrmann, B Stockmeyer, et al.
Cancer Immunology, Immunotherapy : CII
|
January 22, 1998
Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer
H H van Ojik, R Repp, G Groenewegen, et al.
Blood
|
August 15, 1991
Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor
R Repp, T Valerius, A Sendler, et al.
Leukemia & Lymphoma
|
July 1, 1997
HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies
T Valerius, D Elsässer, R Repp, et al.
Nucleic Acids Research
|
October 11, 1992
A novel murine homeobox gene isolated by a tissue specific PCR cloning strategy
M J Kern, D P Witte, M T Valerius, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
July 1, 1995
Gsh-1: a novel murine homeobox gene expressed in the central nervous system
M T Valerius, H Li, J L Stock, et al.
Blood
|
November 9, 2000
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma
J Honeychurch, A L Tutt, T Valerius, et al.
Nucleic Acids Research
|
December 15, 1996
An enhancer LEF-1/TCF-1 site is essential for insertion site-independent transgene expression in thymus
T L Haynes, M B Thomas, M R Dusing, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 11, 2018
Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells"
Patrick J Engelberts, Esther C W Breij, T Valerius, et al.
Anticancer Research
|
June 12, 1999
Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma
D Elsässer, H Stadick, S Stark, et al.
Page
of 7